Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
國立臺灣大學
/
醫學院
/
外科
CHEN-HSIANG KUAN
研究人員網路
瀏覽統計
Email 通知
RSS Feed
簡歷
研究成果
34
計畫
5
研究成果
(全部)
全部
期刊文章
回顧型論文
其他
顯示/隱藏過濾條件
依作者
5
chen-hsiang kuan
5
wang t.-w.
3
jui-sheng sun
3
wang l.-w.
2
chang c.-w.
2
chen m.-h.
2
lin c.-j.
1
chang y.-c.
1
chen l.-h.
1
chen y.
.
下一頁 >
主題
3
[sdgs]sdg3
1
amino acids; calcium phosphate; cell proliferation; controlled drug delivery; diseases; endothelial cells; ethylene glycol; ligands; nanoparticles; oncology; pathology; polyethylene glycols; polyols; targeted drug delivery; tumors; breast cancer; breast cancer cells; nanocarriers; ph-responsive; poly(l-histidine); poly-(l-glutamic acid); poly-l-glutamic acids; programmable ph responsive; self-assembling; tumor microenvironments; peptides; aconitic acid; amphophile; calcium phosphate; copolymer; doxorubicin; leucine; ligand; macrogol; nanocarrier; nanoparticle; polyglutamic acid; polyhistidine; polypeptide; doxorubicin; drug carrier; nanoparticle; peptide; acidity; antineoplastic activity; aqueous solution; article; biodegradability; breast cancer; cancer therapy; cell proliferation; circulation time; controlled study; drug delivery system; drug efficacy; drug release; human; human cell; hydrophobicity; in vitro study; lymph vessel endothelium; mda-mb-231 cell line; metastasis inhibition; micelle; mineralization; nanoencapsulation; particle size; ph; priority journal; proton transport; tumor microenvironment; breast tumor; chemistry; delayed release formulation; drug design; metabolism; pathology; pharmacology; tumor cell line; umbilical vein endothelial cell; breast neoplasms; cell line, tumor; delayed-action preparations; doxorubicin; drug carriers; drug design; human umbilical vein endothelial cells; humans; hydrogen-ion concentration; nanoparticles; peptides
1
biomaterial; carbon; folic acid; imine; nanoparticle; poly(ethylene imine); polyethylene derivative; small interfering rna; animal; chemistry; disease model; gene expression; gene silencing; gene transfer; genetics; human; lung neoplasms; male; materials testing; molecular imaging; mouse; oxidation reduction reaction; particle size; reporter gene; theranostic nanomedicine; transgene; tumor cell line; ultrastructure; animals; biocompatible materials; carbon; cell line, tumor; disease models, animal; folic acid; gene expression; gene silencing; gene transfer techniques; genes, reporter; humans; imines; lung neoplasms; male; materials testing; mice; molecular imaging; nanoparticles; oxidation-reduction; particle size; polyethylenes; rna, small interfering; theranostic nanomedicine; transgenes
1
covalent bonds; diagnosis; drug delivery; fish; grafting (chemical); hyaluronic acid; nanoparticles; nuclear magnetic resonance spectroscopy; organic acids; particle size; peptides; ph sensors; solutions; transmission electron microscopy; tumors; active targeting; cancer therapy; dual responsive; orthotopic; self-assembling; diseases; cystamine; dithiothreitol; doxorubicin; glutathione; gonadorelin; hyaluronic acid; nanoconjugate; antineoplastic antibiotic; delayed release formulation; doxorubicin; nanoconjugate; peptide; animal cell; animal experiment; antineoplastic activity; article; controlled release formulation; controlled study; drug delivery system; drug uptake; female; human; human cell; in vitro study; light scattering; mouse; nonhuman; ovarian cancer cell line; ovary cancer; ph; priority journal; proton nuclear magnetic resonance; ring opening; synthesis; theranostic nanomedicine; tissue section; transmission electron microscopy; animal; chemistry; delayed release formulation; drug delivery system; drug effects; ovarian neoplasms; ovary; oxidation reduction reaction; pathology; procedures; theranostic nanomedicine; tumor cell line; animals; antibiotics, antineoplastic; cell line, tumor; cystamine; delayed-action preparations; doxorubicin; drug delivery systems; female; humans; hyaluronic acid; hydrogen-ion concentration; mice; nanoconjugates; ovarian neoplasms; ovary; oxidation-reduction; peptides; theranostic nanomedicine
依日期
5
2010 - 2019
依類型
5
journal article
全文
5
no fulltext
關閉過濾條件
再查詢
作者:
wu h.-c.
第 1 到 5 筆結果,共 5 筆。
公開日期
標題
作者
來源出版物
scopus
WOS
全文
1
2018
Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration
Jian W.-H.; Wang H.-C.; CHEN-HSIANG KUAN
; Chen M.-H.; Wu H.-C.; JUI-SHENG SUN
; Wang T.-W.
Biomaterials
50
44
2
2017
Multichanneled Nerve Guidance Conduit with Spatial Gradients of Neurotrophic Factors and Oriented Nanotopography for Repairing the Peripheral Nervous System
Chang Y.-C.; Chen M.-H.; Liao S.-Y.; Wu H.-C.; CHEN-HSIANG KUAN
; JUI-SHENG SUN
; Wang T.-W.
ACS Applied Materials and Interfaces
90
78
3
2017
Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy
Wang T.-W.; Yeh C.-W.; CHEN-HSIANG KUAN
; Wang L.-W.; Chen L.-H.; Wu H.-C.; JUI-SHENG SUN
Acta Biomaterialia
40
37
4
2016
Multi-functionalized carbon dots as theranostic nanoagent for gene delivery in lung cancer therapy
Wu Y.-F.; Wu H.-C.; CHEN-HSIANG KUAN
; Lin C.-J.; Wang L.-W.; Chang C.-W.; Wang T.-W.
Scientific Reports
162
146
5
2016
Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics
Lin C.-J.; CHEN-HSIANG KUAN
; Wang L.-W.; Wu H.-C.; Chen Y.; Chang C.-W.; Huang R.-Y.; Wang T.-W.
Biomaterials
68
60
申請連結研究人員資料
以 ORCID 登入申請連結此個人資料
ORCID Login
Contact via feedback form
若您要聯絡網站管理員,請點選以下按鈕